Tech Company Financing Transactions
Purespring Therapeutics Funding Round
Purespring Therapeutics, operating out of London, raised $105 million in investment from Sofinnova Partners, British Patient Capital and Forbion Capital Partners.
Transaction Overview
Company Name
Announced On
10/9/2024
Transaction Type
Venture Equity
Amount
$105,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to support its pipeline including the initiation of a Phase I/II clinical trial for IgAN, a common, chronic kidney disease primarily affecting young adults. Proceeds will be used to support the initiation of a Phase I/II clinical trial for IgAN, a common, chronic kidney disease primarily affecting young adults.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Rolling Stock Yard, 188 York Way
London, N7 9AS
UK
London, N7 9AS
UK
Phone
Website
Email Address
Overview
Purespring is developing gene therapies to halt or prevent kidney disease, one of humankind's most poorly treated disease areas. Purespring's platform approach enables streamlined gene therapy development for both monogenic and non-monogenic renal diseases, offering the potential to halt, reverse and even cure both rare and common kidney diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
John Tsai
Chief Executive Officer
Julian Hanak
Chief Financial Officer
Sachin Kelkar
Chief Medical Officer
Fredrik Erlandsson
Chief Scientific Officer
Alice Brown
Co-Founder
Moin Saleem
VP - Human Resources
Peter Mulcahy
Browse more venture capital transactions:
Prev: 10/9/2024: Delta venture capital transaction
Next: 10/9/2024: Prime Security venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to document all VC transactions involving tech companies. All VC database entries on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs